China to manufacture TB vaccine
Tuberculosis vaccines may become affordable and readily available to the developing world, as China’s expanding role as a vaccine manufacturer becomes visible in global health.
According to World Health Organisation (WHO) about 2 billion people live with latent TB and globally it is responsible for the death of 1.4 million people annually. Vaccines are the most cost-effective biomedical intervention in medical history.
But as much as tuberculosis has created a public health crisis in the developing world, it is also a major public health priority in China, where there are more than one million new TB cases every year. .....
Unlock for 2 fraxions
Login to fraxion payments
